News Image

Halozyme to Participate at Upcoming Investor Conferences

Provided By PR Newswire

Last update: Aug 28, 2025

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Tram Bui, VP of Investor Relations and Corporate Communications, are scheduled to participate and host investor meetings at the following investor conferences. 

Read more at prnewswire.com